FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions, in general, refers to treatment of system infections caused by yeast and mold organisms, in particular, to a pharmaceutical composition for treating a disease caused by fungi, yeast or mold fungi, suitable for parenteral administration, containing an antifungal azole pharmaceutical agent and a solvent, said solvent comprising a) an alcohol component selected from benzyl alcohol and/or acidified ethanol, and b) polyethylene glycol (PEG), wherein the azole agent is dissolved in said solvent, wherein the composition is substantially free of nonionic surfactants and contains less than 5 % water, where the antifungal azole pharmaceutical is selected from a group consisting of: miconazole, ketoconazole, clotrimazole, econazole, omoconazole, bifonazole, butoconazole, fenticonazole, isoconazole, oxiconazole, sertaconazole, sulconazole, tioconazole, fluconazole, isavuconazole, ravuconazole, voriconazole, terconazole and abafungin. Group of inventions also relates to a method of producing said composition, as well as to a method of treating diseases caused by fungi, yeast or mold fungi, and use of the composition for preparing a medicinal agent.
EFFECT: disclosed are pharmaceutical preparations of azoles for parenteral administration and methods for preparing and using them for treating diseases which are sensitive to azole compounds.
33 cl, 3 ex, 11 tbl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL AZOLES PREPARATION FOR PARENTERAL INJECTION AND METHODS OF PRODUCTION AND APPLICATION FOR TREATMENT OF DISEASES, SENSITIVE TO AZOLE COMPOUNDS | 2011 |
|
RU2618456C2 |
INITIAL ANTICONVULSANT COMPOSITIONS AND A METHOD FOR ADMINISTERING ANTICONVULSANT AGENTS | 2000 |
|
RU2264209C2 |
PHARMACEUTICAL COMPOSITION FOR PARENTERAL DELIVERY IN FORM OF LYOPHILIZATE AND METHOD OF ITS OBTAINING | 2007 |
|
RU2370258C2 |
FULVESTRANT COMPOSITIONS | 2018 |
|
RU2684330C1 |
LYOPHILISED PREPARATION OF CYTOTOXIC DIPEPTIDES | 2012 |
|
RU2597154C2 |
STABLE EMULSION FOR PARENTERAL INTRODUCTION OF BADLY SOLUBLE IN WATER COMPOUNDS, WHICH HAVE ANTI-TUMOR ACTIVITY, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2370261C2 |
MELATONIN-BASED SOLUTIONS AND POWDERS FOR THEIR PREPARATION | 2012 |
|
RU2646802C2 |
PROSTACYCLIN ANALOGUE PREPARATIONS | 2017 |
|
RU2757903C2 |
PHARMACEUTICAL COMPOSITIONS BASED ON INDOMETHACIN MENTHYL ETHER AND THEIR APPLICATION AS ANTI-INFLAMMATORY AGENTS | 2017 |
|
RU2685257C1 |
COMPOSITION OF BCL-2 INHIBITOR BASED ON CYCLODEXTRIN | 2019 |
|
RU2804366C2 |
Authors
Dates
2020-10-13—Published
2011-12-16—Filed